TruTouch Technologies completes human clinical trials of its finger-touch detection system

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has successfully carried out human clinical trials of its newest finger-touch detection system for alcohol intoxication, in collaboration with Lovelace Scientific Resources. The trial is intended to support continued product commercialization and new technology development for the device, called TruTouch 2000.

“TruTouch's mission is to help eliminate alcohol-related dangers on our roadways and in our workplaces, by providing a simple, accurate and cost-effective test to ensure driver and equipment operator safety.”

TruTouch and Lovelace Scientific Resources carried out a comparison alcohol level detection study in 55 patients, comparing effectiveness and sensitivity of the newly developed TruTouch 2000 finger touch device with the TruTouch Guardian forearm device, breathalyzer and the current gold standard for intoxication detection, venous blood.

Dr. Richard D. Gill, President and CEO of TruTouch, said, "We are delighted to announce the successful calibration of our newly developed TruTouch 2000, which will help advance commercialization of our current TruTouch intoxication detection systems. These systems are already enjoying success in the law enforcement support, oil drilling, military and transportation operation markets. Additionally, we are looking forward to a successful launch through OEM partners into Medical, Workplace & Point of Sale markets."

He added, "TruTouch's mission is to help eliminate alcohol-related dangers on our roadways and in our workplaces, by providing a simple, accurate and cost-effective test to ensure driver and equipment operator safety."

The TruTouch Guardian and TruTouch 2000 are advanced intoxication detection devices that use light, instead of bodily fluids or other means, to measure a subject's alcohol level. With the TruTouch 2000, a subject places a finger on an infrared scanning system, which then analyzes the level of intoxicant in the subject's system. The device can produce accurate results in less than 15 seconds, and has a built-in biometric identification system to ensure test result integrity.

Unlike a Breathalyzer, the TruTouch Guardian and TruTouch 2000 devices require no user training, no disposables, no samples, and need no operator assistance.

Current and future TruTouch applications include:

  • Medical Diagnostic Systems
  • Workplace Safety Systems
  • Alcohol Point-Of-Sale Liability Reduction Systems
  • Law Enforcement Systems
  • Industrial Safety Systems
  • Vehicle Safety Systems

Source: TruTouch Technologies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Substance use, high alcohol consumption may increase the risk of new-onset atrial fibrillation